DH Definitive Healthcare Corp.

Nasdaq definitivehc.com


$ 2.94 $ 0.28 (10.57 %)    

Friday, 07-Nov-2025 15:59:54 EST
QQQ $ 612.14 $ 1.56 (0.26 %)
DIA $ 470.45 $ 1.64 (0.35 %)
SPY $ 672.31 $ 2.95 (0.44 %)
TLT $ 89.45 $ -0.19 (-0.21 %)
GLD $ 367.77 $ 0.35 (0.1 %)
$ 2.93
$ 2.74
$ 2.60 x 1
$ 3.01 x 1
$ 2.70 - $ 2.99
$ 2.15 - $ 5.68
508,950
na
302.68M
$ 1.80
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2025 09-30-2025 10-Q
2 08-07-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 02-27-2025 01-01-1970 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-05-2024 06-30-2024 10-Q
7 05-07-2024 03-31-2024 10-Q
8 02-28-2024 12-31-2023 10-K
9 11-02-2023 09-30-2023 10-Q
10 08-14-2023 06-30-2023 10-Q
11 05-04-2023 03-31-2023 10-Q
12 02-27-2023 12-31-2022 10-K
13 11-03-2022 09-30-2022 10-Q
14 08-04-2022 06-30-2022 10-Q
15 05-05-2022 03-31-2022 10-Q
16 03-15-2022 12-31-2021 10-K
17 11-08-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 definitive-healthcare-raises-fy2025-adj-eps-guidance-from-022-023-to-023-024-vs-023-est-raises-fy2025-sales-guidance-from-237000m-240000m-to-239000m-240000m-vs-238424m-est

Definitive Healthcare (NASDAQ:DH) raises FY2025 Adj EPS guidance from $0.22-$0.23 to $0.23-$0.24 vs $0.23 analyst estimate. Rai...

 definitive-healthcare-sees-q4-adj-eps-005-006-vs-006-est-sees-sales-59000m-60000m-vs-59148m-est

Definitive Healthcare (NASDAQ:DH) is looking for Q4 Adj EPS of $0.05-$0.06 vs $0.06 analyst estimate. sees sales of $59.000 mil...

 definitive-healthcare-q3-adj-eps-007-beats-006-estimate-sales-60046m-beat-59488m-estimate

Definitive Healthcare (NASDAQ:DH) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $...

 stifel-maintains-buy-on-definitive-healthcare-raises-price-target-to-6

Stifel analyst David Grossman maintains Definitive Healthcare (NASDAQ:DH) with a Buy and raises the price target from $5 to $6.

 definitive-healthcare-raises-fy2025-adj-eps-guidance-from-020-023-to-022-023-vs-021-est-raises-fy2025-sales-guidance-from-234000m-240000m-to-237000m-240000m-vs-237041m-est

Definitive Healthcare (NASDAQ:DH) raises FY2025 Adj EPS guidance from $0.20-$0.23 to $0.22-$0.23 vs $0.21 analyst estimate. Rai...

 definitive-healthcare-sees-q3-adj-eps-005-006-vs-006-est-sees-sales-59000m-60000m-vs-59215m-est

Definitive Healthcare (NASDAQ:DH) is looking for Q3 Adj EPS of $0.05-$0.06 vs $0.06 analyst estimate. sees sales of $59.000 mil...

 definitive-healthcare-q2-adj-eps-007-beats-005-estimate-sales-60750m-beat-59200m-estimate

Definitive Healthcare (NASDAQ:DH) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $...

 goldman-sachs-maintains-neutral-on-definitive-healthcare-raises-price-target-to-34

Goldman Sachs analyst Kash Rangan maintains Definitive Healthcare (NASDAQ:DH) with a Neutral and raises the price target fro...

 definitive-healthcare-raises-fy25-outlook-adj-eps-from-019-022-to-020-023-vs-021-est-sales-from-23000m-24000m-to-23400m-24000m-vs-23428m-est

Full Year 2025:  Revenue is expected to be in the range of $234.0 – $240.0 million, raising the bottom end of our prior range b...

 definitive-healthcare-sees-q2-adj-eps-004-005-vs-005-est-sees-sales-58500m-60000m-vs-5829m-est

Second Quarter 2025:  Revenue is expected to be in the range of $58.5 – $60.0 million. Adjusted Operating Income is expected to...

 definitive-healthcare-q1-adj-eps-005-beats-002-estimate-sales-5919m-beat-5618m-estimate

Definitive Healthcare (NASDAQ:DH) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION